AMN Healthcare (AMN) Q2 2025: International Nurse Revenue Down $100M From Peak, Setting Up Double-Digit Recovery Path
AMN Healthcare navigated a turbulent Q2 marked by policy-driven client caution, volume pressure, and a $100 million drop in international nurse staffing revenue from its 2023 peak, but signs of stabilization and targeted innovation signal a multi-year recovery opportunity. Strategic divestitures, operational automation, and a diversified business mix are positioning AMN to capitalize on industry consolidation and renewed demand for flexible staffing as legislative uncertainty abates. Management expects sequential improvement, with international and labor disruption segments poised for outsized growth into 2026.
Summary
- International Nurse Staffing Turns the Corner: Revenue base reset sets up double-digit growth ahead.
- Operational Discipline Offsets Demand Headwinds: Automation and cost controls bolster margin stability amid volume declines.
- Industry Consolidation Tailwind Emerges: AMN’s scale and solutions advantage grows as smaller competitors weaken.
Performance Analysis
AMN Healthcare’s Q2 2025 results reflect a sector grappling with government policy uncertainty and demand volatility. Consolidated revenue landed at $658 million, with the nurse and allied segment accounting for $382 million, down 14% year-over-year. Travel nurse revenue, a core acute care business, fell 25% from the prior year, while allied revenue declined more modestly at 4%. Labor disruption revenue, an episodic but high-margin driver, contributed $16 million versus zero a year ago, highlighting the growing importance of this segment as collective bargaining activity accelerates.
Gross margin performance was a relative bright spot, with consolidated margin at 29.8%, aided by favorable business mix, payroll tax benefits, and one-off items. SG&A discipline was evident, with underlying costs in the low $130 million range after excluding reserves and bad debt, reflecting ongoing automation and process improvements. However, the quarter was marred by a $110 million goodwill impairment in physician and leadership solutions, and an $18 million intangible write-down in nurse and allied, underscoring the impact of volume pressure and market reset. Operating cash flow remained solid at $79 million, boosted by labor disruption deposits, while leverage was managed down to 3.3x.
- Travel Nurse Weakness Concentrated in Academic Medical Centers: These clients, 20% of revenue, drove most of the volume decline due to funding cuts and hiring freezes.
- Allied and Locum Segments Show Resilience: Allied orders rose 3% from March to July, and locum tenens demand is up 5% sequentially, diversifying AMN’s revenue base.
- Technology and Language Services Face Pricing Pressure: Language utilization grew 6% YoY but was offset by competitive price compression, while VMS revenue dropped 31% YoY.
Overall, AMN’s performance reflects a business in transition, with stabilization in several segments and a clear path to recovery as policy clarity improves and client demand normalizes.
Executive Commentary
"With the new tax bill now finalized, our clients have some clarity on future changes to reimbursement and their insured population mix, much of which will happen gradually over several years. July saw improvement in key metrics across most of our businesses. In nurse and allied, traveler extension rates rebounded sharply in July, which underscores that our clients still have the need for flexible staffing."
Carrie Grace, President and Chief Executive Officer
"The underlying spreads in nurse and allied have been more stable. So, yeah, we did have a little bit of better gross margin performance from what we guided... our focus right now is actually on just trying to drive as much volume as possible. And there's been pretty stable bill rates. And so that is a pretty stable margin. And we would expect to see that as we go into the third and fourth quarter as well."
Brian Scott, Chief Financial and Operating Officer
Strategic Positioning
1. International Nurse Staffing: Reset and Recovery
AMN’s international nurse business, which peaked at $225 million in 2023, has declined to $125 million due to visa retrogression, but management expects a return to double-digit revenue and EBITDA growth in 2026. The pipeline supports a multi-year recovery, and EBITDA margins remain above 30%, making this segment a critical future growth lever.
2. Labor Disruption and Strike Support: Scaling for Opportunity
The labor disruption business is emerging as a differentiator, with $16 million revenue in Q2 and a conservative $5 million guide for Q3, though management sees upside potential as more collective bargaining agreements come due. Recent technology investments enable AMN to scale strike support without disrupting core operations, positioning the company to win larger, higher-margin deals.
3. Technology Platform Rationalization and Automation
The sale of SmartSquare scheduling software for $75 million reflects a disciplined approach to capital allocation, freeing resources for higher-growth areas and removing friction with potential technology partners. Automation initiatives, notably the AMN Passport app, now assist over 20% of nurse and allied placements, boosting fill rates and operational efficiency.
4. Diversification and Share Stabilization
AMN’s business mix is more diversified than ever, with Allied, Locum Tenens, and Language Services providing ballast against acute care volatility. The company retained or gained market share in key segments, according to Staffing Industry Analysts, and is positioned to benefit from industry consolidation as smaller competitors struggle.
5. Managed Services Program (MSP) Evolution
MSP revenue is on track for a historic high, with a shift back toward supplier-led models as clients seek risk-sharing and fill rate reliability. AMN’s ability to serve both vendor-neutral and direct models broadens its addressable market and strengthens client relationships.
Key Considerations
AMN’s Q2 reflects a business balancing demand resets with operational innovation and strategic repositioning. Investors should weigh the following:
Key Considerations:
- Demand Normalization Signals: July saw stabilization in nurse demand and sequential improvement in allied and locum, suggesting the bottom may be in for volume declines.
- Cost Control and Margin Management: Automation and process improvements are offsetting volume-driven margin pressure, with underlying SG&A now in the low $130 million range.
- Labor Disruption Upside: Strike support pipeline is robust, with significant revenue potential in Q4 and 2026 tied to large CBAs.
- Competitive Environment and Consolidation: AMN’s scale and technology investments are positioning it to take share as private competitors face financial stress and industry consolidation accelerates.
- Technology Monetization and Focus: Divestiture of non-core platforms like SmartSquare is sharpening focus on scalable, high-impact solutions such as Passport and AI-enabled event management.
Risks
AMN faces ongoing regulatory risk, especially around immigration and healthcare funding, which could delay international nurse recovery or suppress client demand. Competitive pricing pressure, particularly in language services and VMS, threatens margin stability. Episodic labor disruption revenue introduces forecasting volatility, and impairment charges highlight the risk of further volume-driven write-downs if demand recovery stalls.
Forward Outlook
For Q3 2025, AMN guided to:
- Consolidated revenue of $610 to $625 million
- Gross margin of 28.7% to 29.2%
- SG&A at approximately 23% of revenue
- Adjusted EBITDA margin of 7.7% to 8.2%
For full-year 2025, management maintained a cautious but constructive tone, highlighting:
- Sequential stabilization in nurse and allied demand
- Upside potential in labor disruption and international nurse segments as legislative clarity and visa processing improve
Takeaways
AMN’s Q2 reveals a business at an inflection point, with operational discipline and technology investment setting the stage for a multi-year recovery as demand stabilizes and industry consolidation favors scaled players.
- International Nurse Recovery Is the Key Growth Lever: A $100 million revenue reset provides a low base for double-digit growth as visa retrogression eases, with high EBITDA margins supporting profit expansion.
- Labor Disruption and Automation Drive Competitive Advantage: Scalable strike support and Passport automation are proving differentiators as clients seek cost-effective, flexible staffing solutions.
- Watch for Volume Inflection and Share Gains: Stabilizing order trends and a robust MSP pipeline suggest AMN is poised to capture incremental share as client confidence returns and smaller rivals falter.
Conclusion
AMN Healthcare is leveraging operational agility, strategic divestitures, and technology-enabled solutions to weather a challenging demand environment and emerge stronger. With stabilization underway and key growth levers set to inflect, AMN is well-positioned for a multi-year recovery as industry dynamics shift in its favor.
Industry Read-Through
AMN’s results highlight the fragility and opportunity in healthcare staffing as policy uncertainty and funding cuts pressure demand, particularly for acute care and academic medical centers. The shift toward diversified revenue streams, automation, and scalable labor disruption solutions is likely to accelerate industry consolidation, favoring well-capitalized, tech-enabled players. Competitive pricing in language and VMS segments signals ongoing margin compression across the sector, while the international nurse recovery underscores the importance of regulatory clarity for supply-constrained labor markets. Other staffing and workforce solutions providers should prepare for heightened volatility and the need for operational flexibility as the cycle turns.